INDV Indivior Plc
Price (delayed)
$9.52
Market cap
$1.19B
P/E Ratio
476
Dividend/share
N/A
EPS
$0.02
Enterprise value
$1.24B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline
Highlights
The net income has surged by 102% year-on-year and by 102% since the previous quarter
The EPS has soared by 102% YoY and by 102% from the previous quarter
The equity has plunged by 108% from the previous quarter and by 82% YoY
Indivior's debt has increased by 33% YoY and by 32% from the previous quarter
Key stats
What are the main financial stats of INDV
Market
Valuations
Earnings
Shares outstanding
124.66M
Market cap
$1.19B
Enterprise value
$1.24B
Price to earnings (P/E)
476
Price to book (P/B)
N/A
Price to sales (P/S)
1.06
EV/EBIT
23.01
EV/EBITDA
14.97
EV/Sales
1.05
Revenue
$1.19B
Gross profit
$957M
Operating income
$32M
Net income
$2M
EBIT
$54M
EBITDA
$83M
Free cash flow
$7M
Per share
Balance sheet
Liquidity
EPS
$0.02
EPS diluted
$0.02
Free cash flow per share
$0.05
Book value per share
-$2.52
Revenue per share
$9
TBVPS
$9.95
Total assets
$1.32B
Total liabilities
$1.67B
Debt
$375M
Equity
-$348M
Working capital
-$100M
Debt to equity
-1.08
Current ratio
0.89
Quick ratio
0.61
Net debt/EBITDA
0.67
Margins
Efficiency
Dividend
EBITDA margin
7%
Gross margin
80.6%
Net margin
0.2%
Operating margin
2.7%
Return on assets
0.1%
Return on equity
N/A
Return on invested capital
15.3%
Return on capital employed
14.2%
Return on sales
4.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INDV stock price
How has the Indivior stock price performed over time
Intraday
1.49%
1 week
-1.75%
1 month
3.03%
1 year
-54.32%
YTD
-23.41%
QTD
-0.1%
Financial performance
How have Indivior's revenue and profit performed over time
Revenue
$1.19B
Gross profit
$957M
Operating income
$32M
Net income
$2M
Gross margin
80.6%
Net margin
0.2%
The operating income has surged by 121% since the previous quarter and by 120% year-on-year
INDV's operating margin has surged by 120% since the previous quarter and by 119% year-on-year
Indivior's net margin has soared by 102% from the previous quarter and by 102% YoY
The net income has surged by 102% year-on-year and by 102% since the previous quarter
Growth
What is Indivior's growth rate over time
Valuation
What is Indivior stock price valuation
P/E
476
P/B
N/A
P/S
1.06
EV/EBIT
23.01
EV/EBITDA
14.97
EV/Sales
1.05
The EPS has soared by 102% YoY and by 102% from the previous quarter
The equity has plunged by 108% from the previous quarter and by 82% YoY
The stock's price to sales (P/S) is 39% less than its last 4 quarters average of 1.7
INDV's revenue is up by 9% year-on-year
Efficiency
How efficient is Indivior business performance
The ROS has soared by 143% YoY and by 142% from the previous quarter
Indivior's return on invested capital has surged by 142% QoQ and by 131% YoY
Indivior's ROA has soared by 101% YoY and by 101% from the previous quarter
Dividends
What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INDV.
Financial health
How did Indivior financials performed over time
Indivior's total assets is 21% lower than its total liabilities
Indivior's total assets has decreased by 25% YoY and by 10% QoQ
The quick ratio has grown by 20% YoY and by 3.4% from the previous quarter
The equity has plunged by 108% from the previous quarter and by 82% YoY
The debt to equity is up by 36% since the previous quarter and by 27% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.